0000950170-24-002701.txt : 20240108
0000950170-24-002701.hdr.sgml : 20240108
20240108080005
ACCESSION NUMBER: 0000950170-24-002701
CONFORMED SUBMISSION TYPE: 3
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240105
FILED AS OF DATE: 20240108
DATE AS OF CHANGE: 20240108
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: DelAversano Robert J
CENTRAL INDEX KEY: 0001728262
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 3
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35776
FILM NUMBER: 24518378
MAIL ADDRESS:
STREET 1: 217 W. MAIN STREET
CITY: SOMERVILLE
STATE: NJ
ZIP: 08876
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Acasti Pharma Inc.
CENTRAL INDEX KEY: 0001444192
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 000000000
STATE OF INCORPORATION: A8
FISCAL YEAR END: 0331
BUSINESS ADDRESS:
STREET 1: 103 CARNEGIE CENTER
STREET 2: SUITE 300
CITY: PRINCETON
STATE: NJ
ZIP: 08540
BUSINESS PHONE: 609-649-9272
MAIL ADDRESS:
STREET 1: 103 CARNEGIE CENTER
STREET 2: SUITE 300
CITY: PRINCETON
STATE: NJ
ZIP: 08540
3
1
ownership.xml
3
X0206
3
2024-01-05
0
0001444192
Acasti Pharma Inc.
ACST
0001728262
DelAversano Robert J
103 CARNEGIE CENTER
SUITE 300
PRINCETON
NJ
08540
false
true
false
false
Vice President, Finance
Stock Options (Right to Buy)
2.125
2033-12-19
Class A Common Shares
42000
D
(1) Stock options granted on December 19, 2023 under the Acasti Pharma Inc. Stock Option Plan, which options vest in equal quarterly installments over a period of 36 months.
/s/ Robert J. DelAversano
2024-01-08